Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Acumen Pharmaceuticals Inc (NQ: ABOS ) 3.250 +0.030 (+0.93%) Streaming Delayed Price Updated: 10:39 AM EDT, May 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 34,867 Open 3.240 Bid (Size) 3.250 (2) Ask (Size) 3.260 (2) Prev. Close 3.220 Today's Range 3.225 - 3.320 52wk Range 1.810 - 11.31 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting April 16, 2024 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease April 04, 2024 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Performance YTD -23.17% -23.17% 1 Month -18.95% -18.95% 3 Month -1.22% -1.22% 6 Month +73.80% +73.80% 1 Year -17.51% -17.51% More News Read More Acumen Pharmaceuticals's Earnings: A Preview March 25, 2024 Via Benzinga Acumen Pharmaceuticals's Earnings Outlook November 10, 2023 Via Benzinga ABOS Stock Earnings: Acumen Pharmaceuticals Misses EPS for Q4 2023 March 26, 2024 Via InvestorPlace Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights March 26, 2024 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Acumen Pharmaceuticals to Present Deeper Insights, Including Fluid Biomarker Data for Sabirnetug (ACU193), During Emerging Science Session at the American Academy of Neurology Annual Meeting March 21, 2024 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024 March 19, 2024 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Earnings Scheduled For March 26, 2024 March 26, 2024 Via Benzinga Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days March 12, 2024 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting March 08, 2024 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting February 21, 2024 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer February 01, 2024 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot January 30, 2024 Via InvestorPlace 3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom January 24, 2024 Via InvestorPlace Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 04, 2024 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Are You A Trader Or Investor: Biotech Momentum Is Picking Up November 20, 2023 Via Talk Markets Topics ETFs Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning November 17, 2023 Via Investor's Business Daily Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights November 13, 2023 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures November 13, 2023 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Earnings Scheduled For November 13, 2023 November 13, 2023 Via Benzinga Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures November 09, 2023 Via InvestorPlace 3 Promising Biotech Stocks Flying Under the Radar November 08, 2023 Via InvestorPlace Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference November 07, 2023 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Acumen Pharmaceuticals to Report Third Quarter Financial Results on November 13, 2023 November 06, 2023 From Acumen Pharmaceuticals, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
